An antidepressant medication named duloxetine has been recalled by the U.S. Food and Drug Administration (FDA) due to the presence of carcinogenic chemicals. The drug was voluntarily recalled by a ...

dosage and administration, cost, and place in therapy of duloxetine for major depression, pain from diabetic peripheral neuropathy, and stress urinary incontinence are reviewed. Summary ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic ...

For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...

Find all the commercial and brand names of generic drug called Duloxetine. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

The Food and Drug Administration (FDA ... daily intake limits for 70 years does not increase cancer risk. Duloxetine is a selective serotonin and norepinephrine reuptake inhibitors (SNRIs).

The researchers decided to compare the safety of gabapentin against that of duloxetine, another drug prescribed for nerve ...

More than 233,000 bottles of the antidepressant duloxetine have been recalled because of a chemical that contains the risk of cancer, public health officials said. The U.S. Food and Drug ...

In studies, with nearly 30,000 patients, there was "moderate" evidence for only one drug, duloxetine, and just for short-term pain relief. And there was a "shocking" lack of long-term data ...